世界のトレプロ​​スチニル治療薬市場予測 2021年-2026年

【英語タイトル】Global Treprostinil Drugs Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21JL16159)・商品コード:LPI21JL16159
・発行会社(調査会社):LP Information
・発行日:2021年7月(※2024年版があります。お問い合わせください)
・ページ数:136
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「トレプロ​​スチニル治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、リモジュリン、タイバソ、オレニトラムなど、用途別には、病院、診療所などにセグメント区分してまとめました。トレプロ​​スチニル治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・トレプロ​​スチニル治療薬の世界市場概要(サマリー)
・トレプロ​​スチニル治療薬の企業別販売量・売上
・トレプロ​​スチニル治療薬の企業別市場シェア
・トレプロ​​スチニル治療薬の世界市場規模 2016年-2021年:種類別(リモジュリン、タイバソ、オレニトラム)
・トレプロ​​スチニル治療薬の世界市場規模 2016年-2021年:用途別(病院、診療所)
・トレプロ​​スチニル治療薬の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・トレプロ​​スチニル治療薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・トレプロ​​スチニル治療薬のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・トレプロ​​スチニル治療薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・トレプロ​​スチニル治療薬市場の成長要因・課題・動向
・トレプロ​​スチニル治療薬の世界市場予測 2021年-2026年
・トレプロ​​スチニル治療薬の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・トレプロ​​スチニル治療薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・トレプロ​​スチニル治療薬のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・トレプロ​​スチニル治療薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・トレプロ​​スチニル治療薬の世界市場予測:種類別(リモジュリン、タイバソ、オレニトラム)
・トレプロ​​スチニル治療薬の世界市場予測:用途別(病院、診療所)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Treprostinil Drugs will have significant change from previous year. By the most conservative estimates of global Treprostinil Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1210.8 million in 2020. Over the next five years the Treprostinil Drugs market will register a 0.7% CAGR in terms of revenue, the global market size will reach US$ 1246.3 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Treprostinil Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Remodulin
Tyvaso
Orenitram
The sales proportion of remodulin in 2018 is about 60%, and the sale proportion of Tyvaso is about 23% in 2018.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
The most proportion of treprostinil drugs is used for hospitals, and the proportion in 2018 is about 52%.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
United Therapeutics
Novartis
Teva

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Treprostinil Drugs Consumption 2016-2026
2.1.2 Treprostinil Drugs Consumption CAGR by Region
2.2 Treprostinil Drugs Segment by Type
2.2.1 Remodulin
2.2.2 Tyvaso
2.2.3 Orenitram
2.3 Treprostinil Drugs Sales by Type
2.3.1 Global Treprostinil Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Treprostinil Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Treprostinil Drugs Sale Price by Type (2016-2021)
2.4 Treprostinil Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Treprostinil Drugs Sales by Application
2.5.1 Global Treprostinil Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Treprostinil Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Treprostinil Drugs Sale Price by Application (2016-2021)

3 Global Treprostinil Drugs by Company
3.1 Global Treprostinil Drugs Sales Market Share by Company
3.1.1 Global Treprostinil Drugs Sales by Company (2019-2021)
3.1.2 Global Treprostinil Drugs Sales Market Share by Company (2019-2021)
3.2 Global Treprostinil Drugs Revenue Market Share by Company
3.2.1 Global Treprostinil Drugs Revenue by Company (2019-2021)
3.2.2 Global Treprostinil Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Treprostinil Drugs Sale Price by Company
3.4 Global Manufacturers Treprostinil Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Treprostinil Drugs Product Location Distribution
3.4.2 Players Treprostinil Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Treprostinil Drugs by Region
4.1 Global Treprostinil Drugs by Region
4.1.1 Global Treprostinil Drugs Sales by Region
4.1.2 Global Treprostinil Drugs Revenue by Region
4.2 Americas Treprostinil Drugs Sales Growth
4.3 APAC Treprostinil Drugs Sales Growth
4.4 Europe Treprostinil Drugs Sales Growth
4.5 Middle East & Africa Treprostinil Drugs Sales Growth

5 Americas
5.1 Americas Treprostinil Drugs Sales by Country
5.1.1 Americas Treprostinil Drugs Sales by Country (2016-2021)
5.1.2 Americas Treprostinil Drugs Revenue by Country (2016-2021)
5.2 Americas Treprostinil Drugs Sales by Type
5.3 Americas Treprostinil Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Treprostinil Drugs Sales by Region
6.1.1 APAC Treprostinil Drugs Sales by Region (2016-2021)
6.1.2 APAC Treprostinil Drugs Revenue by Region (2016-2021)
6.2 APAC Treprostinil Drugs Sales by Type
6.3 APAC Treprostinil Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Treprostinil Drugs by Country
7.1.1 Europe Treprostinil Drugs Sales by Country (2016-2021)
7.1.2 Europe Treprostinil Drugs Revenue by Country (2016-2021)
7.2 Europe Treprostinil Drugs Sales by Type
7.3 Europe Treprostinil Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Treprostinil Drugs by Country
8.1.1 Middle East & Africa Treprostinil Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Treprostinil Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Treprostinil Drugs Sales by Type
8.3 Middle East & Africa Treprostinil Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Treprostinil Drugs Distributors
10.3 Treprostinil Drugs Customer

11 Global Treprostinil Drugs Market Forecast
11.1 Global Treprostinil Drugs Forecast by Region
11.1.1 Global Treprostinil Drugs Forecast by Regions (2021-2026)
11.2.2 Global Treprostinil Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Treprostinil Drugs Forecast by Type
11.7 Global Treprostinil Drugs Forecast by Application

12 Key Players Analysis
12.1 United Therapeutics
12.1.1 United Therapeutics Company Information
12.1.2 United Therapeutics Treprostinil Drugs Product Offered
12.1.3 United Therapeutics Treprostinil Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 United Therapeutics Main Business Overview
12.1.5 United Therapeutics Latest Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis Treprostinil Drugs Product Offered
12.2.3 Novartis Treprostinil Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Treprostinil Drugs Product Offered
12.3.3 Teva Treprostinil Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Teva Main Business Overview
12.3.5 Teva Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Treprostinil Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Remodulin
Table 3. Major Players of Tyvaso
Table 4. Major Players of Orenitram
Table 5. Global Treprostinil Drugs Sales by Type (2016-2021) & (K Units)
Table 6. Global Treprostinil Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Treprostinil Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Treprostinil Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Treprostinil Drugs Sale Price by Type (2016-2021)
Table 10. Global Treprostinil Drugs Sales by Application (2016-2021) & (K Units)
Table 11. Global Treprostinil Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Treprostinil Drugs Value by Application (2016-2021)
Table 13. Global Treprostinil Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Treprostinil Drugs Sale Price by Application (2016-2021)
Table 15. Global Treprostinil Drugs Sales by Company (2019-2021) & (K Units)
Table 16. Global Treprostinil Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Treprostinil Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Treprostinil Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Treprostinil Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Treprostinil Drugs Producing Area Distribution and Sales Area
Table 21. Players Treprostinil Drugs Products Offered
Table 22. Treprostinil Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Treprostinil Drugs Sales by Region (2016-2021) (K Units)
Table 26. Global Treprostinil Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Treprostinil Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Treprostinil Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Treprostinil Drugs Sales by Country (2016-2021) & (K Units)
Table 30. Americas Treprostinil Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Treprostinil Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Treprostinil Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Treprostinil Drugs Sales by Type (2016-2021) & (K Units)
Table 34. Americas Treprostinil Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Treprostinil Drugs Sales by Application (2016-2021) & (K Units)
Table 36. Americas Treprostinil Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Treprostinil Drugs Sales by Region (2016-2021) & (K Units)
Table 38. APAC Treprostinil Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Treprostinil Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Treprostinil Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Treprostinil Drugs Sales by Type (2016-2021) & (K Units)
Table 42. APAC Treprostinil Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Treprostinil Drugs Sales by Application (2016-2021) & (K Units)
Table 44. APAC Treprostinil Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Treprostinil Drugs Sales by Country (2016-2021) & (K Units)
Table 46. Europe Treprostinil Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Treprostinil Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Treprostinil Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Treprostinil Drugs Sales by Type (2016-2021) & (K Units)
Table 50. Europe Treprostinil Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Treprostinil Drugs Sales by Application (2016-2021) & (K Units)
Table 52. Europe Treprostinil Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Treprostinil Drugs Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Treprostinil Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Treprostinil Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Treprostinil Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Treprostinil Drugs Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Treprostinil Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Treprostinil Drugs Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Treprostinil Drugs Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Treprostinil Drugs
Table 62. Key Application and Potential Industries of Treprostinil Drugs
Table 63. Key Challenges of Treprostinil Drugs
Table 64. Key Trends of Treprostinil Drugs
Table 65. Treprostinil Drugs Distributors List
Table 66. Treprostinil Drugs Customer List
Table 67. Global Treprostinil Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Treprostinil Drugs Consumption Market Forecast by Region
Table 69. Global Treprostinil Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Treprostinil Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Treprostinil Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Treprostinil Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Treprostinil Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Treprostinil Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Treprostinil Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Treprostinil Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Treprostinil Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Treprostinil Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Treprostinil Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Treprostinil Drugs Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Treprostinil Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Treprostinil Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Treprostinil Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Treprostinil Drugs Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Treprostinil Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Treprostinil Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 87. United Therapeutics Basic Information, Treprostinil Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. United Therapeutics Treprostinil Drugs Product Offered
Table 89. United Therapeutics Treprostinil Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 90. United Therapeutics Main Business
Table 91. United Therapeutics Latest Developments
Table 92. Novartis Basic Information, Treprostinil Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis Treprostinil Drugs Product Offered
Table 94. Novartis Treprostinil Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
Table 97. Teva Basic Information, Treprostinil Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Treprostinil Drugs Product Offered
Table 99. Teva Treprostinil Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 100. Teva Main Business
Table 101. Teva Latest Developments
List of Figures
Figure 1. Picture of Treprostinil Drugs
Figure 2. Treprostinil Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Treprostinil Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Treprostinil Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Treprostinil Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Remodulin
Figure 10. Product Picture of Tyvaso
Figure 11. Product Picture of Orenitram
Figure 12. Global Treprostinil Drugs Sales Market Share by Type in 2020
Figure 13. Global Treprostinil Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Treprostinil Drugs Consumed in Hospital
Figure 15. Global Treprostinil Drugs Market: Hospital (2016-2021) & (K Units)
Figure 16. Treprostinil Drugs Consumed in Clinic
Figure 17. Global Treprostinil Drugs Market: Clinic (2016-2021) & (K Units)
Figure 18. Global Treprostinil Drugs Sales Market Share by Application (2016-2021)
Figure 19. Global Treprostinil Drugs Revenue Market Share by Application in 2020
Figure 20. Treprostinil Drugs Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Treprostinil Drugs Revenue Market Share by Company in 2020
Figure 22. Global Treprostinil Drugs Sales Market Share by Regions (2016-2021)
Figure 23. Global Treprostinil Drugs Revenue Market Share by Region in 2020
Figure 24. Americas Treprostinil Drugs Sales 2016-2021 (K Units)
Figure 25. Americas Treprostinil Drugs Revenue 2016-2021 ($ Millions)
Figure 26. APAC Treprostinil Drugs Sales 2016-2021 (K Units)
Figure 27. APAC Treprostinil Drugs Revenue 2016-2021 ($ Millions)
Figure 28. Europe Treprostinil Drugs Sales 2016-2021 (K Units)
Figure 29. Europe Treprostinil Drugs Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Treprostinil Drugs Sales 2016-2021 (K Units)
Figure 31. Middle East & Africa Treprostinil Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Americas Treprostinil Drugs Sales Market Share by Country in 2020
Figure 33. Americas Treprostinil Drugs Revenue Market Share by Country in 2020
Figure 34. Americas Treprostinil Drugs Sales Market Share by Type in 2020
Figure 35. Americas Treprostinil Drugs Sales Market Share by Application in 2020
Figure 36. United States Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Treprostinil Drugs Sales Market Share by Region in 2020
Figure 41. APAC Treprostinil Drugs Revenue Market Share by Regions in 2020
Figure 42. APAC Treprostinil Drugs Sales Market Share by Type in 2020
Figure 43. APAC Treprostinil Drugs Sales Market Share by Application in 2020
Figure 44. China Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Treprostinil Drugs Sales Market Share by Country in 2020
Figure 51. Europe Treprostinil Drugs Revenue Market Share by Country in 2020
Figure 52. Europe Treprostinil Drugs Sales Market Share by Type in 2020
Figure 53. Europe Treprostinil Drugs Sales Market Share by Application in 2020
Figure 54. Germany Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Treprostinil Drugs Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Treprostinil Drugs Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Treprostinil Drugs Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Treprostinil Drugs Sales Market Share by Application in 2020
Figure 63. Egypt Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Treprostinil Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


★調査レポート[世界のトレプロ​​スチニル治療薬市場予測 2021年-2026年] (コード:LPI21JL16159)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトレプロ​​スチニル治療薬市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆